Birdwatch Note
2024-05-25 21:04:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Pan, de maneira irresponsável, está passando informação errada sobre um remédio utilizado incorretamente para emagrecimento. O estudo citado se refere a pacientes que possuem diabetes e outras doenças. As consequências para emagrecimento não são claras e podem ser perigosas. https://www.washingtonpost.com/health/2024/05/24/ozempic-kidney-disease-study/
Written by F2EF069FC12F6C5905BE89393A162BDD6BD4AE0761294E2B37A7C8298478BE02
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1794454970634555623
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1794474542661796222
- noteId - 1794474542661796222
- participantId -
- noteAuthorParticipantId - F2EF069FC12F6C5905BE89393A162BDD6BD4AE0761294E2B37A7C8298478BE02
- createdAtMillis - 1716671045353
- tweetId - 1794454970634555623
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Pan, de maneira irresponsável, está passando informação errada sobre um remédio utilizado incorretamente para emagrecimento. O estudo citado se refere a pacientes que possuem diabetes e outras doenças. As consequências para emagrecimento não são claras e podem ser perigosas. https://www.washingtonpost.com/health/2024/05/24/ozempic-kidney-disease-study/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-05-25 21:04:05 UTC (1716671045353) |
2024-05-26 00:18:23 UTC (1716682703443) |
CURRENTLY_RATED_HELPFUL | 2024-05-26 01:23:46 UTC (1716686626098) |
CURRENTLY_RATED_HELPFUL | 2024-05-26 00:18:23 UTC (1716682703443) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-05-25 17:44:31 -0500 | Rating Details | |
| 2024-05-25 17:19:44 -0500 | Rating Details | |
| 2024-05-25 17:10:24 -0500 | Rating Details | |
| 2024-05-25 17:05:47 -0500 | Rating Details | |
| 2024-05-25 16:59:52 -0500 | Rating Details | |
| 2024-05-25 16:12:51 -0500 | Rating Details | |
| 2024-05-25 16:09:24 -0500 | Rating Details | |
| 2024-05-25 16:08:42 -0500 | Rating Details | |
| 2024-05-25 16:06:34 -0500 | Rating Details | |
| 2024-05-26 07:58:35 -0500 | Rating Details | |
| 2024-05-25 22:06:58 -0500 | Rating Details | |
| 2024-05-25 18:39:56 -0500 | Rating Details | |
| 2024-05-25 18:22:11 -0500 | Rating Details | |
| 2024-05-25 17:21:12 -0500 | Rating Details | |
| 2024-05-25 17:18:36 -0500 | Rating Details | |
| 2024-05-25 17:09:17 -0500 | Rating Details | |
| 2024-05-25 16:36:14 -0500 | Rating Details | |
| 2024-05-25 16:16:46 -0500 | Rating Details | |
| 2024-05-25 16:12:22 -0500 | Rating Details | |
| 2024-05-27 06:40:20 -0500 | Rating Details | |
| 2024-05-26 09:07:48 -0500 | Rating Details | |
| 2024-05-25 19:36:20 -0500 | Rating Details | |
| 2024-05-25 19:34:31 -0500 | Rating Details | |
| 2024-05-25 18:38:03 -0500 | Rating Details | |
| 2024-05-25 18:36:44 -0500 | Rating Details | |
| 2024-05-25 18:21:58 -0500 | Rating Details | |
| 2024-05-25 17:55:15 -0500 | Rating Details | |
| 2024-05-25 17:48:25 -0500 | Rating Details | |
| 2024-05-25 17:35:17 -0500 | Rating Details | |
| 2024-05-25 16:46:59 -0500 | Rating Details | |
| 2024-05-25 16:19:16 -0500 | Rating Details | |
| 2024-05-27 07:16:35 -0500 | Rating Details |